α-PD-L1/DLL3 CAR-T

· Sichuan University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for α-PD-L1/DLL3 CAR-T, covering 2025-05-16 to 2025-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC [Phase 1]